These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33954019)

  • 21. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma.
    Mariani G; Gipponi M; Moresco L; Villa G; Bartolomei M; Mazzarol G; Bagnara MC; Romanini A; Cafiero F; Paganelli G; Strauss HW
    J Nucl Med; 2002 Jun; 43(6):811-27. PubMed ID: 12050328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
    Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
    Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype.
    Fargnoli MC; Sera F; Suppa M; Piccolo D; Landi MT; Chiarugi A; Pellegrini C; Seidenari S; Peris K
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1768-75. PubMed ID: 24588892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
    Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
    Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive and Prognostic Value of BRAF and NRAS Mutation of 159 Sentinel Lymph Node Cases in Melanoma-A Retrospective Single-Institute Study.
    Liszkay G; Mátrai Z; Czirbesz K; Jani N; Bencze E; Kenessey I
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.
    Macerola E; Loggini B; Giannini R; Garavello G; Giordano M; Proietti A; Niccoli C; Basolo F; Fontanini G
    Virchows Arch; 2015 Aug; 467(2):177-84. PubMed ID: 26055532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system.
    Vahabzadeh-Hagh AM; Blackwell KE; Abemayor E; St John MA
    Am J Otolaryngol; 2018; 39(5):485-488. PubMed ID: 29803536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRAF mutation status might contribute an effect on both disease-free and overall survival in stage III cutaneous melanomas treated with intermediate dose interferon-alpha.
    Tas F; Erturk K
    Cancer Chemother Pharmacol; 2019 Sep; 84(3):521-526. PubMed ID: 30997532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.
    Blaheta HJ; Ellwanger U; Schittek B; Sotlar K; MacZey E; Breuninger H; Thelen MH; Bueltmann B; Rassner G; Garbe C
    J Invest Dermatol; 2000 Apr; 114(4):637-42. PubMed ID: 10733666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis?
    Han D; Han G; Morrison S; Leong SP; Kashani-Sabet M; Vetto J; White R; Schneebaum S; Pockaj B; Mozzillo N; Sondak VK; Zager JS
    Surgery; 2020 Sep; 168(3):518-526. PubMed ID: 32669204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.
    Han D; Thomas DC; Zager JS; Pockaj B; White RL; Leong SP
    World J Clin Oncol; 2016 Apr; 7(2):174-88. PubMed ID: 27081640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
    Naffouje S; Naffouje R; Bhagwandin S; Salti GI
    Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel Lymph Node Biopsy in Cutaneous Melanoma: Standard and New Technical Procedures and Clinical Advances. A Systematic Review of the Literature.
    Tardelli E; Mazzarri S; Rubello D; Gennaro M; Fantechi L; Duce V; Romanini A; Chondrogiannis S; Volterrani D; Colletti PM; Manca G
    Clin Nucl Med; 2016 Dec; 41(12):e498-e507. PubMed ID: 27749418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors of primary cutaneus melanoma.
    Noveski L; Zhivadinovik J; Matveeva N
    Med Pregl; 2014; 67(11-12):392-8. PubMed ID: 25675830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between sentinel lymph node status and regression of primary malignant melanoma.
    Liszkay G; Orosz Z; Péley G; Csuka O; Plótár V; Sinkovics I; Bánfalvi T; Fejõs Z; Gilde K; Kásler M
    Melanoma Res; 2005 Dec; 15(6):509-13. PubMed ID: 16314736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of surgery on the course of melanoma.
    Lejeune FJ
    Recent Results Cancer Res; 2002; 160():151-7. PubMed ID: 12079209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.
    Barbour AP; Tang YH; Armour N; Dutton-Regester K; Krause L; Loffler KA; Lambie D; Burmeister B; Thomas J; Smithers BM; Hayward NK
    Eur J Cancer; 2014 Oct; 50(15):2668-76. PubMed ID: 25070294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study.
    Maza S; Valencia R; Geworski L; Sandrock D; Zander A; Audring H; Dräger E; Winter H; Sterry W; Munz DL
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):538-44. PubMed ID: 12582814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.